SomaLogic, Inc. (Nasdaq: SLGC), relating to its proposed sale to Standard BioTools Inc. Under the terms of the agreement, SLGC shareholders will receive 1.11 shares of Standard BioTools per share they own
SomaLogic, Inc. (Nasdaq: SLGC), relating to its proposed sale to Standard BioTools Inc. Under the terms of the agreement, SLGC shareholders will receive 1.11 shares of Standard BioTools per share they own